Digital breast tomosynthesis (DBT) value in breast mass detection

Authors

  • Angelika Kuczyska II Department of Medical Radiology, Medical University of Lublin Author
  • Łukasz Kwietniewski II Department of Medical Radiology, Medical University of Lublin Author
  • Wiktor Kupisz II Department of Medical Radiology, Medical University of Lublin Author
  • Joanna Kruk-Bachonko II Department of Medical Radiology, Medical University of Lublin Author
  • Witold Krupski II Department of Medical Radiology, Medical University of Lublin Author

DOI:

https://doi.org/10.2478/pjph-2020-0001

Keywords:

digital breast tomosynthesis, breast cancer, mammography

Abstract

Epidemiologically, breast cancer is the most common cancer in middle-aged women and it is one of the leading causes of cancer-related deaths. Middle-aged patients are covered by screening tests – digital mammography, often supplemented with ultrasound (US) breast examination. Other radiological tests in the diagnosis of breast cancer include such techniques as tomosynthesis, spectral mammography and magnetic resonance imaging (MRI). Many research groups around the world have demonstrated superiority of tomosynthesis in detecting focal lesions in breasts when compared to conventional mammography. Tomosynthesis usage was proposed for screening studies as a test of choice and for radiologically-guided tissue biopsies of suspicious tissue lesions

References

1. Rogaliński M. Tomosynteza – nowa nadzieja mammografii. IFM. 2014;3:91-2.

2. Roganovic D, Djilas D, Vujnovic S, et al. Breast MRI, digital mammography and breast tomosynthesis: Comparison of three methods for early detection of breast cancer. Bosn J Basic Med Sci. 2015;15(4):64-8.

3. Kisielewicz K, Dziecichowicz A, Sapikowska A, et al. Dawki dla pacjentek poddawanych cyfrowej tomosyntezie w mammografii. IFM. 2019;8:267.

4. Tabár L, Vitak B, Chen TH-H, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658-63.

5. Agasthya GA, D’Orsi E, Kim YJ, et al. Can breast compression be reduced in digital mammography and breast tomosynthesis? AJR. 2017;209(5):322-32.

6. Gilbert FJ. Digital breast tomosynthesis (DBT): a review of the evidence for use as a screening tool. Clin Radiol. 2016;71(2):141-50.

7. Skaane P. Breast cancer screening with digital breast tomosynthesis. Breast Cancer. 2017;24(1):32-41.

8. Nguyen T, Levy G, Poncelet E, et al. Overview of digital breast tomosynthesis: Clinical cases, benefits and disadvantages. Diagn Interv Imaging. 2015;96:843-59.

9. Hooley RJ, Durand MA, Philpotts LE. Advances in digital breast tomosynthesis. AJR. 2017;208:256-66.

10. Johnson MM. Full-field digital mammography and digital breast tomosynthesis. Radiol Technol. 2017;88(3):299M-319M.

11. Spak DA, Plaxco JS, Santiago L, et al. BI-RADS® fifth edition: A summary of changes. Diagn Interv Imaging. 2017;98(3):179-90.

12. Mall S, Lewis S, Brennan P, Noakes J. The role of digital breast tomosynthesis in the breast assessment clinic: a review. J Med Radiat Sci. 64 2017;203-11.

13. Kopans D, Gavenonis S, Halpern E, Moore R. Calcifications in the breast and digital breast tomosynthesis. Breast J. 2011;17:638-44.

14. Spangler ML, Zuley ML, Sumkin JH, et al. Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: A comparison. Am J Roentgenol 2011;196:320-4.

15. Garcia-Leon FJ, Liamos-Mendez A, Jsabel-Gómez R. Digital tomosynthesis in breast cancer: A systematic review. Radiologia. 2015; 57(4):333-43.

16. Tabár L, Yen AMF, Wu WYY, et al. Insights from the breast cancer screening trials: How creening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J. 2015;21:13-20.

17. Funaro K, Drukteinis J, Falcon S. Screening mammography and digital breast tomosynthesis: Controversies. South Med J. 2017;110(10):607-13.

18. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081-7.

19. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, hysical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165-75

20. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film ammography for breast-cancer screening. N Engl J Med. 2005; 353:1773-83.

21. Smith RA, Duffy SW, Gabe R, et al. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004;42:793-806.

22. Svahn TM, Houssami N, Sechopoulos I, et al. Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view fullfield digital mammography. Breast 2015;24:93-9.

23. Shin SU, Chang JM, Bae MS, et al. Comparative evaluation of average glandular dose and breast cancer detection between single-view digital breast tomosynthesis (DBT) plus single-view digital mammography (DM) and two-view DM: correlation with breast thickness and density. Eur Radiol 2015; 25:1-8.

Downloads

Published

2021-01-13